Passive stretch regulates skeletal muscle glucose uptake independent of nitric oxide synthase by Kerris, Jarrod P et al.
1 
 
Passive stretch regulates skeletal muscle glucose uptake independent  1 
of nitric oxide synthase 2 
 3 
Jarrod P. Kerris
1,2
, Andrew C. Betik
1,3
, Jinhua Li
4
,
 
and Glenn K. McConell
1,2 
 4 
 5 
1
 Institute for Health and Sport, Victoria University, Melbourne, Australia  6 
2 
College of Sport & Exercise Science, Victoria University, Melbourne, Australia 7 
3
 College of Health and Biomedicine, Victoria University, Melbourne, Australia  8 
4
 Department of Anatomy and Developmental Biology, Monash Biomedicine 9 
Discovery Institute, Monash University, Clayton, Australia 10 
 11 
 12 
Running title: Stretch, NO and glucose uptake 13 
 14 
Corresponding Author: 15 
 16 
Jarrod P Kerris 17 
Institute for Health and Sport 18 
Victoria University, Melbourne, VIC 3011 19 
Phone: +61400833563 20 
Email: jarrod.kerris@live.vu.edu.au  21 
2 
 
Abstract 22 
Skeletal muscle contraction increases glucose uptake via an insulin-independent 23 
mechanism. Signaling pathways arising from mechanical strain are activated during 24 
muscle contractions, and mechanical strain in the form of passive stretching 25 
stimulates glucose uptake. However, the exact mechanisms regulating stretch-26 
stimulated glucose uptake are not known. Since nitric oxide synthase (NOS) has been 27 
implicated in the regulation of glucose uptake during ex vivo and in situ muscle 28 
contractions and during exercise, and NO is increased with stretch, we examined 29 
whether the increase in muscle glucose uptake during stretching involves NOS. We 30 
passively stretched isolated EDL muscles (15 min at ~100-130 mN) from control 31 
mice and mice lacking either neuronal NOSµ (nNOSµ) or endothelial NOS (eNOS) 32 
isoforms, as well as used pharmacological inhibitors of NOS. Stretch significantly 33 
increased muscle glucose uptake approximately 2-fold (P < 0.05), and this was 34 
unaffected by the presence of the NOS inhibitors N
G
-monomethyl-L-arginine (L-35 
NMMA; 100 µM) or N
G
-nitro-L-arginine methyl ester (L-NAME; 100 µM). 36 
Similarly, stretch-stimulated glucose uptake was not attenuated by deletion of either 37 
eNOS or nNOSµ isoforms. Furthermore, stretching failed to increase skeletal muscle 38 
NOS enzymatic activity above resting levels. These data clearly demonstrate that 39 
stretch-stimulated skeletal muscle glucose uptake is not dependent on NOS. 40 
 41 
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New & Noteworthy 43 
Passive stretching is known to activate muscle glucose uptake through mechanisms 44 
that partially overlap with contraction. We report that genetic knockout of eNOS or 45 
nNOS or pharmacological NOS inhibition does not affect stretch-stimulated glucose 46 
uptake. Passive stretch failed to increase NOS activity above resting levels. This 47 
information is important for the study of signaling pathways that regulate stretch-48 
stimulated glucose uptake and indicate that NOS should be excluded as a potential 49 
signaling factor in this regard. 50 
  51 
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INTRODUCTION 52 
Exercise and ex vivo and in situ muscle contractions potently stimulate the uptake of 53 
glucose into skeletal muscle via a signaling pathway that is, at least proximally, 54 
independent of the canonical insulin signaling pathway (35). Signaling proteins that 55 
mediate glucose uptake during exercise present as an attractive therapeutic target for 56 
the treatment of Type 2 diabetes since glucose uptake and GLUT-4 translocation 57 
during contraction and exercise are mostly normal in insulin resistant muscle (24, 29, 58 
53). However, the exact mechanisms involved remain to be fully clarified. 59 
 60 
The transduction of mechanical stimuli into biochemical signals has long been known 61 
to regulate biological processes in skeletal muscle (9, 16, 50). Several studies have 62 
shown that mechanical loading applied to isolated rodent muscles in the form of 63 
passive stretching increases muscle glucose uptake (5, 18, 20, 23, 45), presumably via 64 
stimulating GLUT4 translocation (45). It is likely that a mechanical signaling 65 
component is essential to fully activate the glucose transport machinery during 66 
contractions, as the prevention of tension development during electrically-induced 67 
skeletal muscle contractions attenuates the increase in glucose uptake (2, 18, 23, 45). 68 
While muscle contractions have been shown to induce metabolic disturbances and 69 
activation of AMP-activated protein kinase (AMPK), this pathway is not activated by 70 
stretch (5, 23, 45). On the other hand, passive stretching activates the cytoskeletal 71 
regulator Rac1, and Rac1 inhibition has been shown to attenuate stretch-stimulated 72 
glucose uptake (44, 45). However, Rac1 inhibition does not affect the increase in 73 
glucose uptake during electrical stimulations when tension development is prevented 74 
(45). This indicates that during muscle contraction mechanical stimuli activates a 75 
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distinct signaling pathway that contributes to glucose uptake. The exact signaling 76 
mechanisms involved in this pathway are not known. 77 
 78 
Nitric oxide synthase (NOS) activity and nitric oxide (NO) production is increased 79 
during electrical stimulations in muscle cells (34, 42), muscle contractions or exercise 80 
in rodents (14, 15, 31, 32, 36, 38), and exercise in humans (28). Several studies have 81 
demonstrated that pharmacological inhibition of NOS attenuates the increase in 82 
skeletal muscle glucose uptake during contractile activity (1, 3, 14, 24, 31, 32, 37, 38), 83 
although this is not a universal finding (7, 10, 12, 13, 39). Neuronal NOSμ (nNOSμ) 84 
is considered the predominant source of NO in contracting skeletal muscle (14, 26) 85 
and is largely targeted to the mechanosensing dystrophin-glycoprotein complex 86 
(DGC) at the sarcolemma (4). Acute passive stretch of both muscle cells and mature 87 
muscle has also been reported to increase NO production (48, 54, 55), and there is 88 
evidence that NOS is involved in the transduction of mechanical signal pathways 89 
regulating the expression of cytoskeletal proteins (49). Given that NO contributes to 90 
the regulation of glucose uptake during muscle contractions, NO production is 91 
increased by stretch and NOS can participate in mechanical signaling, it is tempting to 92 
speculate that mechanical-stress (stretch) regulates glucose uptake via a NOS-93 
dependent mechanism. However, to the best of our knowledge, no previous study has 94 
investigated the role of NO in the regulation of this pathway.  95 
 96 
Therefore, the aim of this study was to determine whether acute passive stretch 97 
regulates glucose uptake via a NOS-dependent pathway. To determine this, we used 98 
two genetically modified mouse models lacking either eNOS or nNOSµ and two 99 
pharmacological NOS inhibitors which target all NOS isoforms. We hypothesized 100 
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that stretch-stimulated glucose uptake in mouse EDL muscle would be attenuated by 101 
NOS inhibition and/or genetic deletion of nNOSµ. 102 
 103 
Materials and Methods 104 
Animals 105 
All animal experimentation was conducted at the Institute of Sport, Exercise & Active 106 
Living (ISEAL), Victoria University, Melbourne with the prior approval of the 107 
Victoria University Animal Ethics Committee. Animal experimentation adhered to the 108 
Australian Code of Practice for the use and care of animals for scientific purposes as 109 
described by the National Health and Medical Research Council (NHMRC) of 110 
Australia. Thirteen- to sixteen-week-old C57BL/6, eNOS knockout (eNOS
-/-
), and 111 
nNOSµ knockout (nNOSµ
-/-
) mice were involved in this study. Six male mice lacking 112 
eNOS (eNOS
-/-
) (Monash Animal Services, Melbourne, Australia) and eight male 113 
C57BL/6 mice (ARC, Perth, Australia) aged 14–16 weeks were used to examine the 114 
role of eNOS. The eNOS
-/-
 group was generated by using eNOS
-/-
 breeding pairs and 115 
therefore wildtype littermates (eNOS
+/+
) were not produced. Since these mice were 116 
generated on a C57BL/6 background we chose to use C57BL/6 mice as controls. 117 
Seven nNOSµ
-/-
 mice and six wildtype littermates (nNOS
+/+
) (male and female) aged 118 
13–15 weeks were used to examine the role of nNOSµ. nNOSµ-/- (B6, 129-119 
NOS1
tm1plh
) mice were originally purchased from Jackson Laboratories (Bar Harbor, 120 
ME, USA, stock no. 002633) (17) and backcrossed onto a C57BL/6 background for at 121 
least six generations to obtain a colony of nNOS
−/−
 and wild type littermate controls. 122 
Male C57BL/6 mice aged 13–15 weeks (ARC, Perth, Australia) were used for NOS 123 
inhibitor and NOS activity experiments. Mice were housed in standard cages and 124 
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maintained at 21°C on a 12-hour dark/light cycle with access to water and standard 125 
rodent chow ad libitum. Mice were not fasted prior to sacrifice. 126 
 127 
Muscle incubations 128 
NOS inhibition in mice has previously been shown to attenuate the increase in 129 
contraction-stimulated glucose uptake in extensor digitorum longus (EDL) muscles, 130 
but not soleus muscles (32). In addition, electrical stimulations have been shown to 131 
elevate levels of the NO downstream intermediate cGMP in EDL but not soleus 132 
muscles (26). Therefore, only EDL muscles were examined in the present study. EDL 133 
muscles were excised from anaesthetized mice (sodium pentobarbitone 70 mg/kg IP) 134 
and suspended at resting length (~2–4 mN) (45) in organ baths (MultiMyograph 135 
System; Danish Myotechnology, Aarhus, Denmark). All chemicals used were 136 
purchased from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise stated. 137 
Muscles were pre-incubated for 30 min in Krebs-Ringer-Henseleit buffer consisting 138 
of (mM): NaCl 118.5, NaHCO3 24.7, KCl 4.74, MgSO4 1.18, KH2PO4 1.18, CaCl2 139 
2.5, (pH 7.4) supplemented with 0.01% BSA (Cat. # A2153), 8 mM mannitol and 2 140 
mM sodium pyruvate. Incubation media was maintained at 30°C and continuously 141 
oxygenated with gas containing 95% O2 and 5% CO2. Following the 30 min pre-142 
incubation period, muscles either remained at rest or were stretched to a tension of 143 
100–130 mN for 15 minutes (44, 45). When the effects of the NOS inhibitors NG-144 
monomethyl-L-arginine (L-NMMA, 100 μM) (12, 40), and NG-nitro-L-arginine 145 
methyl ester (L-NAME, 100 μM) (40) were examined, these inhibitors were present 146 
during the entire 45 min incubation time. L-NMMA at this concentration has 147 
previously been shown to attenuate the increase in NOS activity by ~90% (12, 31, 40) 148 
and contraction-stimulated glucose uptake during contraction ex vivo in mouse EDL 149 
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by ~20-50% (14, 31, 32). L-NAME has previously been shown to exert a similar 150 
dose-dependent inhibitory effect as L-NMMA on NOS activity in skeletal muscle 151 
(40). Immediately following the 45-min experimental period, muscles were quickly 152 
removed from the organ baths, washed in ice-cold Kreb’s buffer, blotted dry on filter 153 
paper, snap frozen in liquid nitrogen, and stored at -80°C for future analysis. 154 
 155 
Muscle processing 156 
To generate lysates for immunoblotting and NOS activity measurement, whole frozen 157 
EDL muscles were homogenized in ice-cold buffer [50 mM Tris-HCl (pH 7.5), 1 mM 158 
EDTA, 1 mM EGTA, 10% glycerol, 1% Triton X-100, 1 mM DTT, 1 mM 159 
phenylmethylsulfonyl fluoride, 10 μg/ml aprotinin, 5 μl/ml protease inhibitor mixture, 160 
50 mM sodium fluoride, and 5 mM sodium pyrophosphate] by steel beads for 2 x 30 s 161 
30 Hz (TissueLyser, Qiagen, Valencia, CA), followed by end-over-end rotation for 30 162 
min at 4°C. Homogenates were centrifuged at 10,000 g for 20 min at 4°C, and the 163 
supernatant collected for NOS activity measurement. For immunoblotting, an aliquot 164 
was collected prior to the centrifugation step and diluted in sample buffer (0.125 M 165 
Tris-HCl [pH 6.8], 4% SDS, 10% glycerol, 10 mM EGTA, 0.1 M DTT and 0.01% 166 
bromophenol blue) and heated at 95°C for 10 min before being subjected to SDS-167 
PAGE. Protein concentration was determined by the Red660 protein assay kit (G 168 
Biosciences, St Louis, MO). 169 
 170 
Immunoblotting 171 
Total protein (5 µg) was separated by SDS-PAGE using stain-free gels (Bio-Rad, 172 
Hercules, CA) and semi-dry transferred (TransBlot Turbo system, Bio-Rad) to PVDF 173 
membranes. Prior to transfer, a stain-free image of the gel was collected to quantify 174 
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total protein loading. Stain-free gel analysis indicated that no differences in protein 175 
loading were observed. Membranes were blocked for one hour at room temperature 176 
(5% skim milk in TBST), before being probed overnight at 4°C with the following 177 
primary antibodies: p-PAK1/2
Thr423/Thr402
 (1:500), p-P38 MAPK
Thr180/Tyr182 
(1:1000), p-178 
AMPK
Thr172
 (1:1000), and p-CaMKII
Thr286
 (1:1000) (Cell Signaling Technology). The 179 
following day, membranes were incubated with HRP-secondary antibody for 1 hour at 180 
room temperature. Protein bands were visualized using Bio-Rad ChemiDoc imaging 181 
system and enhanced chemiluminescence substrate (SuperSignal West Femto, Pierce, 182 
MA), and quantified using ImageLab software (Bio-Rad). Analysis of protein bands 183 
were normalized to stain-free quantification of protein loading. 184 
 185 
NOS activity and glucose uptake measurements 186 
NOS activity was determined on muscle lysates in duplicate by measuring the 187 
conversion of L-[
14
C] arginine to L-[
14
C] citrulline (14, 27). Muscle glucose uptake 188 
was calculated during the final 10 minutes of stretch or basal conditions by 189 
exchanging the incubation buffer with buffer containing 1 mM 2-deoxy-D-[1,2-
3
H] 190 
glucose (0.128 µCi/mL) and 8 mM D-[
14
C] mannitol (0.083 µCi/mL) (Perkin Elmer, 191 
Boston, MA) as described previously (14). 192 
 193 
Statistical analysis 194 
All data are expressed as mean ± SEM. Statistical analyses were performed using 195 
GraphPad Prism 6.0 software. Glucose uptake was analyzed using one (treatment)- 196 
and two (treatment and genotype)-factor ANOVA. Fisher’s least significance 197 
difference test was performed if the ANOVA revealed a significant difference. 198 
Students t-test was used to compare morphological characteristics between each 199 
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genotype and its relevant control, NOS activity and protein phosphorylation. The 200 
significance level was set at P < 0.05. 201 
 202 
RESULTS 203 
Morphology characteristics of NOS knockout mice 204 
Body mass was not different between C57BL/6 control mice and eNOS
-/-
  mice (28.1 205 
± 0.8 vs. 27.4 ± 1.3 g; P = 0.65; n = 6-8) or between nNOSµ
+/+ 
and nNOSµ
-/- 
mice 206 
(24.1 ± 1.1 vs. 22.4 ± 0.6 g; P = 0.17 n = 6-7). EDL muscle mass was significantly 207 
lower in nNOSµ
-/-
 compared with nNOSµ
+/+
 mice (7.1 ± 0.2 vs. 8.6 ± 0.3 mg; P < 208 
0.001; n = 12-14), whereas EDL mass was similar between C57BL/6 control mice and 209 
eNOS
-/-
 mice (10.5 ± 0.4 vs. 10.1 ± 0.4 mg; P = 0.49 n = 11-15).   210 
 211 
Stretch-stimulated glucose uptake 212 
To investigate the involvement of NOS in the regulation of glucose uptake in 213 
response to mechanical loading, we examined the effects on stretch-stimulated 214 
glucose uptake in EDL muscle of 1) pharmacological NOS inhibition, and 2) deletion 215 
of either eNOS or nNOSµ. In muscles from C57BL/6 mice, passive stretch 216 
significantly increased glucose uptake approximately 2-fold compared with basal 217 
levels (P < 0.001) (Figure 1). Stretch-stimulated glucose uptake was unaffected by the 218 
presence of either of the NOS inhibitors L-NMMA or L-NAME (Figure 1). In 219 
muscles from eNOS
-/-
 mice, stretch increased glucose uptake approximately 2-fold 220 
from basal levels (P < 0.001) with a similar increase observed in C57BL/6 control 221 
mice (Figure 2A). Stretch also increased glucose uptake approximately 2-fold in 222 
muscles from nNOSµ
-/-
 and nNOSµ
+/+
 mice (P < 0.001).  There was a main effect for 223 
nNOSµ
-/-
 indicating that muscles from these mice had elevated basal and stretch-224 
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activated glucose uptake compared with controls (P = 0.02) (Figure 2B). The delta 225 
stretch-stimulated glucose uptake (the difference between basal and stretch values) 226 
was similar between nNOSµ
-/-
 and nNOSµ
+/+
. These results indicate that NOS is not 227 
necessary for normal increases in stretch-stimulated muscle glucose uptake. 228 
 229 
Effect of stretch on NOS activity and protein signaling 230 
Stretch did not increase skeletal muscle NOS activity above basal levels (measure of 231 
contribution from both eNOS and nNOS) in EDL muscles from C57BL/6 mice 232 
(Figure 3A). This was consistent with the lack of effect of deletion of nNOSµ or 233 
eNOS, and the lack of effect of NOS inhibition on stretch-stimulated skeletal muscle 234 
glucose uptake. To confirm that our stretch protocol did actually activate pathways 235 
previously shown to be activated by stretch (5, 23, 45), we examined the 236 
phosphorylation status of p38 MAPK as well as the activation of the cytoskeletal 237 
regulator Rac1 (22) by examining phosphorylation  of the Rac1 downstream kinase 238 
PAK1/2 (44, 45, 51). Consistent with previous studies, stretch significantly increased 239 
the phosphorylation status of PAK1/2
Thr423/402 
and p38 MAPK
Thr180/Tyr182
 (~2-fold) (P 240 
< 0.05) (Figure 3B and C) (5, 23, 44, 45). Skeletal muscle p-AMPK
Thr172
 did not 241 
increase with stretch which was also consistent with previous research (5, 23, 45)  242 
(Figure 3D). Likewise, stretch also failed to increase p-CaMKII
Thr286
 (Figure 3E). 243 
 244 
DISCUSSION 245 
The major finding of this study was that skeletal muscle stretch-induced increases in 246 
glucose uptake are independent of NOS. Given that stretch activated Rac1 (as shown 247 
by increased PAK1/2 phosphorylation) but did not activate NOS, it appears that 248 
although nNOSµ is part of the dystrophin glycoprotein complex and linked to the 249 
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cytoskeleton, stretch induces glucose uptake via the cytoskeleton independently of 250 
nNOSµ. In addition, eNOS is also not required for this process.   251 
 252 
The lack of NOS activation in EDL muscles following stretch is in contrast with other 253 
muscle models whereby stretch increased NO production (43, 47, 48, 54, 55). A key 254 
difference is that most of these studies were conducted in cultured muscle cells where 255 
a much longer stretching/loading protocol (1 – 48 hours) was applied.  Therefore, the 256 
increased NO production reported in these chronic stretch studies may have reflected 257 
an increased NOS protein content (55) rather than activation of the existing NOS. To 258 
our knowledge, only one previous study examined whether acute stretching was 259 
sufficient to stimulate NO production in mature intact muscle (48). Tidball and 260 
colleagues (48) reported a significant increase (~20%) in NO production from isolated 261 
rat soleus muscles following a brief stretch (2 min). In the present study, NO 262 
production probably did not increase with stretch-stimulation given that NOS activity 263 
was not enhanced above resting levels. This inference is in agreement with a previous 264 
study where stretched single mature muscle fibers (10 min) loaded with a NO-265 
sensitive fluorescent probe (DAF-FM), which allowed for a more direct NO 266 
estimation, did not have an increase in NO production (33). It is possible, however, 267 
that static stretching stimulates an initial burst of NOS activity/NO production that 268 
diminishes rapidly over time and was therefore not detected at the time of muscle 269 
harvest in our study (15 min). Indeed, it has been shown that shear stress applied to 270 
endothelial cells resulted in a marked increase in NO production within 5 minutes 271 
followed by little additional NO production thereafter (6). In another study, muscle 272 
NOS activity was significantly elevated 3 minutes following the induction of 273 
increased load applied to plantaris muscles in mice, and despite the continued load, 274 
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NOS activity returned to baseline levels within 1 hour (19). That study is difficult to 275 
interpret, however, given that tendons of synergist muscles were ablated resulting in 276 
“functional overload” of plantaris muscle and the time of overload was defined as 3 277 
minutes after mice started walking post-surgery (19). In our study, it should also be 278 
noted that we did not measure the muscle length required to achieve the passive 279 
tension of 100-130 mN. It is possible that loss of NOS isoforms, or the presence of 280 
NOS inhibitors could have affected the amount of stretch that was required to be 281 
applied to the muscle to achieve the desired passive tension. Nevertheless, the lack of 282 
increase in NOS activity with stretch fits with the observation that stretch-stimulated 283 
glucose uptake was not attenuated by NOS inhibitors or a lack of nNOSµ or eNOS.  284 
 285 
The mechanism(s) by which NOS regulates contraction-stimulated glucose uptake 286 
remains to be determined. Since there is emerging evidence glucose uptake is largely 287 
regulated by distinct metabolic (AMPK)- and mechanical-dependent (Rac1) signaling 288 
arms during muscle contraction (23, 46), in this study we examined the potential 289 
involvement of NOS in a mechanical-dependent signaling pathway. The lack of 290 
involvement of NOS in stretch-stimulated glucose uptake and Rac1 activation 291 
indicates that NOS is not involved in the mechanical signaling arm, and by extension 292 
the possibility that NOS regulates glucose uptake during contraction via a mechanism 293 
coupled with metabolic disturbances. However, this would likely not involve AMPK 294 
(46) given we have previously shown that NOS appears to regulate muscle glucose 295 
uptake during contraction independently of AMPK (30, 32). Nonetheless, it is 296 
important to note that in a recent study (46), although contraction-stimulated glucose 297 
uptake was largely attenuated by blockade of both metabolic (AMPK) and mechanical 298 
(Rac1) signaling, some increase in glucose uptake with contraction was maintained, 299 
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indicating other signaling pathways are likely at play. For example, mTORC2 300 
signaling has been shown to be essential for muscle glucose uptake during exercise in 301 
mice independent of AMPK and Rac1 signaling (25). Therefore, further work is 302 
required to examine the potential involvement of NOS in other signaling pathways 303 
during contraction. 304 
 305 
The activation of Rac1 by contraction and stretch is associated with an increase in 306 
glucose transport in muscle (44, 45), however, the upstream signaling events involved 307 
are largely unknown. Rac1 contains a redox-sensitive motif and it has been reported 308 
that activation of Rac1 is favored in the presence of reactive nitrogen species (11). 309 
Exposure of C2C12 cells to a NO donor has previously been shown to induce the 310 
rapid activation of Rac1 and phosphorylation of its downstream kinase PAK1 (8), 311 
indicating that NO is sufficient to stimulate Rac1 activation. Conversely, nNOS and 312 
eNOS have been reported to be activated by Rac1 in human aortic endothelial cells 313 
(41). These results suggest that NO/NOS could be upstream and/or downstream of 314 
Rac1. We measured PAK1 phosphorylation as a surrogate for Rac1 activity and to 315 
investigate possible associations between NO and Rac1/PAK1 pathway. Our data 316 
indicate that NO is not necessary for Rac1 activation during stretching and vice versa, 317 
given that we observed an increase in stretch-stimulated phosphorylation of PAK1 318 
(and presumably Rac1 activity) without changes in NOS activation. Nonetheless, 319 
future work is required to clarify whether a NO-Rac1 interaction exists in skeletal 320 
muscle under situations where NO bioavailability is increased, such as during muscle 321 
contractions (14). 322 
 323 
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Ca
2+
/Calmodulin-dependent kinase II (CaMKII) has also been implicated in the 324 
regulation of muscle glucose uptake during contractions in mature muscle in situ (52), 325 
however, the inability of stretch to enhance the levels of phosphorylated CaMKII
Thr286
 326 
in our study suggest that CaMKII is not coupled with mechanical signaling 327 
mechanisms. This contrasts with a study where stretch-stimulated glucose uptake in 328 
C2C12 myotubes was blocked by a CaMK inhibitor (21). However, as discussed 329 
above, the pathways regulating stretch-stimulated glucose uptake potentially differ 330 
between in vitro and ex vivo models. 331 
 332 
In conclusion, we have shown that passive stretching does not increase NOS activity 333 
in skeletal muscle and stretch-stimulated glucose uptake is not attenuated by either 334 
pharmacological inhibition of NOS or by deletion of eNOS or nNOSµ isoforms. 335 
Therefore, our results indicate that NOS signaling is not required for stretch-induced 336 
increases in skeletal muscle glucose uptake. 337 
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FIGURE LEGENDS 531 
 532 
Figure 1. NOS inhibition does not attenuate stretch-stimulated skeletal muscle 533 
glucose uptake. Stretch-stimulated 2-deoxyglucose uptake in EDL muscles from 534 
C57BL/6 mice incubated for 30 min with or without the NOS inhibitors L-NMMA 535 
(100 μM) or L-NAME (100 μM) (n = 4-10 per group). Data are means ± SEM. *** P 536 
< 0.001 vs. Basal.  537 
 538 
Figure 2. Deletion of eNOS or nNOSµ does not affect stretch-stimulated skeletal 539 
muscle glucose uptake. 2-deoxyglucose uptake at rest (basal) and during stretch in 540 
EDL muscles of A) C57BL/6 and eNOS
-/-
 mice (n = 5-9 per group) and B) nNOSµ
+/+
 541 
and nNOSµ
-/-
 mice (n = 6-7 per group). Data are means ± SEM. *** P < 0.001 542 
compared to basal. § P < 0.05 main effect for genotype.  543 
 544 
Figure 3. Passive stretch increases phosphorylation of skeletal muscle PAK1/2 545 
and p38 MAPK independently of NOS activation. A) NOS activity of EDL 546 
muscles at rest (basal) or following passive stretch (n = 4 per group). Immunoblot 547 
quantifications for B) p-PAK1/2
Thr423/402
, C) p-p38 MAPK
Thr180/Tyr182
,
 
D) p-548 
AMPK
Thr172
, E) p-CaMKII
Thr286
, and E) representative immunoblots of EDL muscles 549 
at rest (basal) or following passive stretch (n = 4 per group). Data are means ± 550 
S.E.M.* P < 0.05 vs. Basal. 551 
 552 
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